Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial

Mok Chi Chiu; Ho Ling Yin; Ma Kwok Man

首页> 外文期刊>Bone >Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial

【24h】

Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial

机译：慢性糖皮质激素使用者口服双膦酸盐转为地诺单抗：一项为期12个月的随机对照试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: To evaluate the effect of switching from oral bisphosphonates to denosumab on bone mineral density (BMD) in long-term glucocorticoid users.

机译：目的：评估长期口服糖皮质激素使用者从口服双膦酸盐改为地诺单抗对骨矿物质密度（BMD）的影响。

著录项

来源
《Bone》 |2015年第null期|共7页
作者
Mok Chi Chiu; Ho Ling Yin; Ma Kwok Man;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类骨科学（运动系疾病、矫形外科学）;
关键词
Women; Postmenopausal; Osteoporosis; Corticosteroid; Bisphosphonates;

机译：妇女;绝经后;骨质疏松症;皮质类固醇;双膦酸盐;

相似文献

外文文献
中文文献
专利

1. Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial [J] . Mok Chi Chiu, Ho Ling Yin, Ma Kwok Man Bone . 2015,第Null期

机译：慢性糖皮质激素使用者口服双膦酸盐转为地诺单抗：一项为期12个月的随机对照试验
2. Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: A 12-month, randomized, double-blind, placebo-controlled trial [J] . HakalaM., Kr?gerH., VallealaH., Scandinavian journal of rheumatology . 2012,第4期

机译：每月一次口服伊班膦酸可为绝经后使用糖皮质激素治疗炎性风湿病的妇女的骨矿物质密度带来显着改善：一项为期12个月的随机，双盲，安慰剂对照试验
3. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. [J] . Stoch SA, Saag KG, Greenwald M The Journal of rheumatology . 2009,第8期

机译：糖皮质激素引起的骨质疏松患者每周口服一次口服阿仑膦酸盐70毫克：一项为期12个月的随机，安慰剂对照临床试验。
4. Randomized controlled trial comparing of analgesic effectiveness of TPRF and TENs in clinical and endocrinological changes for chronic shoulder pain [C] . Lin Mu-Lien, Luo Yuan-Jie, Hsu Yu-Ming, 4th International Symposium on Bioelectronics and Bioinformatics . 2015

机译：TPRF和TENs对慢性肩痛的临床和内分泌变化镇痛效果的随机对照试验
5. A randomized, double-blind, placebo-controlled, clinical trial of curcuminoids in oral lichen planus. [D] . Wu, Nita Chainani. 2005

机译：口服扁平苔藓中姜黄素类药物的随机，双盲，安慰剂对照临床试验。
6. Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective Randomized Open‐Label Trial [O] . Rui Niimi, Toshibumi Kono, Atsushi Nishihara, 2018

机译：从特立帕肽转用双膦酸盐或地诺单抗的疗效：一项前瞻性随机开放标签试验
7. Faculty Opinions recommendation of Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial. [O] . Sakae Tanaka 2019

机译：教师意见Denosumab对日本类风湿性关节炎患者的建议：AMG 162（Denosumab）对类风湿性关节炎患者对甲氨蝶呤抑制骨侵蚀（驱动）-A的抑制作用（驱动）-A 12个月，Multicentre的抑制作用的剂量 - 反应研究。随机，双盲，安慰剂控制，II期临床试验。

Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial

摘要

著录项

相似文献

相关主题

期刊订阅